Pathways to Optimizing Clinical Outcomes and Quality of Life in Atopic Dermatitis Care

Authors

  • Jensen Yeung, MD, FRCPC Associate Professor, Department of Medicine, University of Toronto, Toronto, ON
  • Julien Ringuet, MD, MSc, FRCPC Principal Investigator, Centre de Recherche Dermatologique de Québec (CRDQ), Quebec, QC. Assistant Professor, Department of Medicine, McGill University, Montreal, QC.

DOI:

https://doi.org/10.58931/cdt.2026.7s01154

Abstract

Many systemic atopic dermatitis (AD) therapies improve the skin before alleviating pruritus. As a result, dermatologists primarily rely on objective skin-focused measures to assess efficacy. Canadian Dermatology Today, spoke with Dr. Jensen Yeung and Dr. Julien Ringuet about the importance of integrating patient-reported outcomes into routine assessment, particularly given the emergence of novel therapies that provide rapid antipruritic benefit.

Author Biographies

Jensen Yeung, MD, FRCPC, Associate Professor, Department of Medicine, University of Toronto, Toronto, ON

Dr. Jensen Yeung obtained a Bachelor of Science (Honours) and his Doctor of Medicine from McMaster University in 2001. The same year, he began his dermatology residency training at the University of Toronto. During his residency training, he spent six months in Australia, New York, and Boston, gaining clinical experience and acquiring the newest knowledge in melanoma and dermoscopy from leading experts. In 2005, he was selected by the residency program as the co-chief resident for the year. Having obtained his board certification from the Royal College of Physicians and Surgeons of Canada in 2006, Dr. Yeung joined the Faculty of Dermatology at the University of Toronto, where he ran teaching clinics at both Women’s College Hospital and the Sunnybrook Health Sciences Centre. In 2007, he was promoted to medical director for the Ricky Kanee Schachter (RKS) Dermatology Program at Women’s College Hospital, where he ran a melanoma, psoriasis, and General Dermatology clinic. In 2013, he switched from RKS to PERC. He took on the new role as the Medical Director of the Phototherapy Education and Research Centre (PERC), where he runs a weekly psoriasis and phototherapy clinic. In 2014, he and Dr. Dana Jerome started a monthly combined psoriasis and psoriatic arthritis clinic at PERC. From 2011 to 2020, he worked at Dr. Kim Papp’s research facility in Waterloo and participated in nearly 200 phase 1 to 4 clinical trials. Dr. Yeung has also supervised and mentored many research students and residents, which has led to more than 250 peer-reviewed publications. He is an associate editor at the American Journal of Clinical Dermatology, Journal of Cutaneous Medicine and Surgery (JCMS), and Canadian Dermatology Today. In addition, he is a Medical Board Member at the National Psoriasis Foundation (NPF) and a councilor at the International Psoriasis Council (IPC). He is an associate professor at the department of Medicine at the University of Toronto.  He has received several teaching awards, including the Best Resident Teacher award in 2005, the 2008 Women’s College Hospital Department of Medicine Postgraduate Teaching Award, the 2009 University of Toronto Dermatology Postgraduate Program Staff Teaching Award, and the 2022-2023 University of Toronto Department of Medicine Excellence in Postgraduate Teaching Award.

Julien Ringuet, MD, MSc, FRCPC, Principal Investigator, Centre de Recherche Dermatologique de Québec (CRDQ), Quebec, QC. Assistant Professor, Department of Medicine, McGill University, Montreal, QC.

Dr. Ringuet is a board certified dermatologist who practices in Quebec City at the Centre de Recherche Dermatologique du Québec Métropolitain (CRDQ) and in Montreal at the McGill University Health Center (MUHC). He obtained a bachelor degree in biology before his medical training (MD) and his dermatology residency at Laval University in Quebec City. During his medical training, he also completed a master in experimental medicine (MSc.) in the field of skin bioengineering at the Centre de Recherche en Organogénèse Expérimentale de l’Université Laval (LOEX). After his post graduate studies and since 2020, Dr. Ringuet is practicing with his team at the Centre de Recherche Dermatologique du Québec Métropolitain (CRDQ) as a principal investigator and medical director. His team is dedicated in allowing Quebec’s patients to access top quality and innovative clinical research focused on inflammatory dermatological diseases. Dr. Ringuet research interests are mainly psoriasis and its variants, atopic dermatitis, vitiligo and alopecia areata. As of today, he led as a principal investigator more then 50 clinical trials of phase 2, 3 and 4 in those indications leading to varied peer reviewed publications, talks and lectures. He also practices in Montreal at the MUHC as an assistant clinical professor since 2025 contributing to the continuous medical education and training of medical students and dermatology residents. His commitment to his peers is also reflected in his role at the Canadian Dermatology Association (CDA) where he took on the role of Treasurer Elect and Treasurer of the Finance and Audit Committee in 2024-2025 and is also a member of the Education Committee from 2024 to present. In addition, he is involved as a reviewer for various journals including the Canadian Medical Association as well as the Journal of Cutaneous Medicine and Surgery (JCMS) for which he stands as an associate editor. Based on his clinical work, commitment to patient care and advancement of the specialty, Dr. Ringuet received the recognition of Dermatologist of the Year 2024 by the Canadian Skin Patient Alliance (CSPA).

References

Yeung J, Gooderham MJ, Hong HC, Lynde C, Prajapati VH, Lansang P, Turchin I, Wiseman M, Jack C, Ramien M, Purdy K, Grewal P. Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective. J Am Acad Dermatol. 2023 Aug;89(2):372-375. doi: 10.1016/j.jaad.2023.01.053. Epub 2023 Apr 19.PMID: 37074241 DOI: https://doi.org/10.1016/j.jaad.2023.01.053

Downloads

Published

2026-01-26

How to Cite

1.
Yeung J, Ringuet J. Pathways to Optimizing Clinical Outcomes and Quality of Life in Atopic Dermatitis Care. Can Dermatol Today [Internet]. 2026 Jan. 26 [cited 2026 Jan. 28];7(s01):2–9. Available from: https://canadiandermatologytoday.com/article/view/7-s01-Yeung_et_al

Issue

Special Supplement, Winter 2026

Section

Articles